Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 60Unknown 16Recruiting 16Terminated 11Active not recruiting 11Withdrawn 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12Pancreatic Neoplasms 6Cholangiocarcinoma 4Cirrhosis, Familial, with Pulmonary Hypertension 3Esophageal Neoplasms 2Biliary Tract Neoplasms 2Stomach Neoplasms 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1PDAC - Pancreatic Ductal Adenocarcinoma 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Metastasis 1Locally Advanced Low Rectal Adenocarcinoma 1Liver Neoplasms 1Liver Metastases of Colorectal Cancer 1Gastroesophageal Junction Cancer 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1CRC 1Biliary Cancer Metastatic 1Appendiceal Neoplasms 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Oxaliplatin 14sintilimab 10S 1 (combination) 9Drug Therapy 7Paclitaxel 5Capecitabine 5tislelizumab 4Surgical Procedures, Operative 4HMPL-013 4apatinib 3Tegafur 3Immune Checkpoint Inhibitors 3Hyperthermic Intraperitoneal Chemotherapy 3Cisplatin 3Bevacizumab 3surufatinib 2potassium oxonate 2lenvatinib 2irinotecan sucrosofate 2gimeracil 2Observation 2Irinotecan 2Injections 2Fluorouracil 2Exercise 2Endoscopic Mucosal Resection 2Doxorubicin 2Docetaxel 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Stomach Neoplasms × Leucovorin × Clear all
NCT07085273 2025-07-31

Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡